LIPO Lipella Pharmaceuticals Inc.

Fundamentals / CIK 0001347242 / USD

Lipella Pharmaceuticals Inc. reported $390K in revenue and a net loss of $5.33M for the trailing twelve months ended September 30, 2025 (down 100.0% year over year), with a -1387.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LIPO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2021 to 2024), reported in USD.

$1.06M$529K$0-$4.74MFY 2021 Revenue: $259KFY 2021 Net Income: -$1.87M2021FY 2022 Revenue: $184KFY 2022 Net Income: -$2.60M2022FY 2023 Revenue: $450KFY 2023 Net Income: -$4.62M2023FY 2024 Revenue: $536KFY 2024 Net Income: -$5.02M2024

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue $536K $450K $184K $259K
Research & Development $3.61M $3.04M $2.55M $1.46M
Operating Income -$5.08M -$4.75M -$2.59M -$1.92M
EBITDA -$5.08M -$4.74M -$2.59M -$1.92M
Interest Income $64K $138K $1.7K $104
Interest Expense -- $11K $9.6K $6.8K
Income Before Tax -$5.02M -$4.62M -$2.60M -$1.87M
Net Income -$5.02M -$4.62M -$2.60M -$1.87M
Basic EPS -$4.79 -$6.16 -$5.12 -$4.40
Diluted EPS -$4.79 -$6.16 -$5.12 -$4.40
Basic Shares Outstanding 1.0M 750.4K 507.6K 426.0K
Diluted Shares Outstanding 1.0M 750.4K 507.6K 426.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue $0 $87K $129K $174K $80K $136K $146K $121K
Research & Development $721K $792K $993K $1.06M $1.05M $662K $843K $454K
Operating Income -$1.27M -$1.36M -$1.33M -$1.45M -$1.46M -$952K -$1.22M -$730K
EBITDA -$1.27M -$1.36M -$1.33M -$1.45M -$1.46M -$951K -$1.22M --
Interest Income $20K $29K $21K $9.6K $15K $14K $26K $41K
Interest Expense -- -- -- -- -- -- -- $0
Income Before Tax -$1.25M -$1.33M -$1.31M -$1.44M -$1.44M -$938K -$1.19M -$689K
Net Income -$1.25M -$1.33M -$1.31M -$1.44M -$1.44M -$938K -$1.19M -$689K
Basic EPS -$0.28 -$0.31 -$0.64 -- -$1.29 -$0.99 -$1.31 --
Diluted EPS -$0.28 -$0.31 -$0.64 -- -$1.29 -$0.99 -$1.31 --
Basic Shares Outstanding 4.5M 4.3M 2.1M -- 1.1M 950.7K 911.5K --
Diluted Shares Outstanding 4.5M 4.3M 2.1M -- 1.1M 950.7K 911.5K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $2.18M $3.29M $5.12M $1.41M
Short-Term Investments -- -- -- $301K
Cash & Short-Term Investments $2.18M $3.29M $5.12M $1.71M
Accounts Receivable, Net $85K $32K $114K --
Total Current Assets $2.62M $3.43M $5.80M $1.81M
Property, Plant & Equipment, Net $9.9K $13K -- --
Total Non-Current Assets $57K $148K $151K $205K
Total Assets $2.67M $3.58M $5.95M $2.01M
Accounts Payable $388K $138K $384K $47K
Other Current Liabilities -- -- $250K $25K
Total Current Liabilities $754K $385K $1.18M $341K
Other Non-Current Liabilities -- -- -- $50K
Total Non-Current Liabilities $0 $47K $96K $249K
Total Liabilities $754K $433K $1.27M $589K
Total Debt (incl. Leases) $48K $137K $155K $208K
Common Stock $121 $75 $574 $387
Retained Earnings -$15.34M -$10.32M -$5.70M -$3.11M
Total Stockholders' Equity $1.92M $3.14M $4.68M $1.42M
Total Equity $1.92M $3.14M $4.68M $1.42M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Cash & Cash Equivalents $1.86M $2.78M $4.23M $2.18M $1.35M $1.19M $2.11M $3.29M
Cash & Short-Term Investments $1.86M $2.78M $4.23M $2.18M $1.35M $1.19M $2.11M $3.29M
Accounts Receivable, Net -- -- -- $85K $31K $35K $69K $32K
Total Current Assets $2.08M $3.44M $4.82M $2.62M $2.08M $2.08M $3.01M $3.43M
Property, Plant & Equipment, Net $7.7K $8.4K $9.1K $9.9K $11K $11K $12K $13K
Total Non-Current Assets $271K $283K $33K $57K $80K $103K $126K $148K
Total Assets $2.35M $3.72M $4.86M $2.67M $2.16M $2.18M $3.14M $3.58M
Accounts Payable $463K $608K $392K $388K $459K $178K $294K $138K
Total Current Liabilities $642K $747K $777K $754K $701K $480K $552K $385K
Total Non-Current Liabilities $220K $232K $1 $0 $0 $0 $24K $47K
Total Liabilities $862K $979K $777K $754K $701K $480K $576K $433K
Total Debt (incl. Leases) $264K $275K $24K $48K $71K $94K $24K $137K
Common Stock $462 $446 $254 $121 $109 $761 $704 $75
Retained Earnings -$19.23M -$17.97M -$16.65M -$15.34M -$13.90M -$12.45M -$11.52M -$10.32M
Total Stockholders' Equity $1.49M $2.74M $4.08M $1.92M $1.46M $1.70M $2.56M $3.14M
Total Equity $1.49M $2.74M $4.08M $1.92M $1.46M $1.70M $2.56M $3.14M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$5.02M -$4.62M -$2.60M -$1.87M
Depreciation & Amortization $2.9K $1.7K $0 $0
Change in Payables $250K -$246K $337K $22K
Operating Cash Flow -$3.95M -$3.15M -$1.83M -$989K
Capital Expenditure -- -$14K -- --
Free Cash Flow -- -$3.16M -- --
Investing Cash Flow -- -$14K $301K -$301K
Common Stock Issued -- -- $4.96M $2.10M
Financing Cash Flow $2.84M $1.34M $5.24M $2.10M
Net Change in Cash -$1.11M -$1.83M $3.71M $807K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Net Income -$1.25M -$1.33M -$1.31M -$1.44M -$1.44M -$938K -$1.19M -$689K
Depreciation & Amortization $722 $721 $722 $721 $722 $722 $721 --
Change in Payables -$145K $216K $3.9K -$71K $281K -$115K $156K -$165K
Operating Cash Flow -$926K -$1.43M -$1.43M -$990K -$653K -$919K -$1.39M -$728K
Common Stock Issued $0 -$10K $3.47M -- $820K $0 $200K --
Financing Cash Flow $0 -$10K $3.47M $1.82M $820K $0 $200K $1.61M
Net Change in Cash -$926K -$1.44M $2.04M $831K $167K -$919K -$1.19M $884K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -947.2% -1055.6% -1406.3% -738.7%
Net Profit Margin -935.2% -1027.3% -1410.6% -719.3%
Return on Equity (ROE) -261.3% -146.9% -55.6% -131.0%
Return on Assets (ROA) -187.6% -129.1% -43.7% -92.7%
Current Ratio 3.47x 8.90x 4.92x 5.31x
Quick Ratio 3.01x 8.63x 4.44x 5.03x
Debt to Equity 0.02x 0.04x 0.03x 0.15x
Revenue Growth (YoY) +19.3% +144.2% -29.0% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Operating Margin -1387.9% -1190.0% -998.5% -947.2% -901.5% -839.1% -1021.9% -1055.6%
Net Profit Margin -1367.4% -1174.1% -987.0% -935.2% -881.7% -816.7% -993.4% -1027.3%
Return on Equity (ROE) -358.3% -201.3% -125.8% -261.3% -292.2% -243.1% -185.2% -146.9%
Return on Assets (ROA) -226.8% -148.4% -105.7% -187.6% -197.4% -189.7% -151.2% -129.1%
Current Ratio 3.24x 4.60x 6.21x 3.47x 2.97x 4.33x 5.46x 8.90x
Quick Ratio 2.89x 3.72x 5.44x 3.01x 1.97x 2.54x 3.94x 8.63x
Debt to Equity 0.18x 0.10x 0.01x 0.02x 0.05x 0.05x 0.01x 0.04x
Revenue Growth (YoY) -100.0% -36.4% -11.3% +43.7% -22.7% +27.9% +23.6% -20.0%
Source: SEC EDGAR CompanyFacts (CIK 0001347242) · from December 31, 2021 Data through September 30, 2025 · synced Nov 21, 2026, 05:17 UTC · Open in terminal